Unique ID issued by UMIN | UMIN000005743 |
---|---|
Receipt number | R000005616 |
Scientific Title | Aggressive antihypertensive treatment for protecting cardiovascular complications in diabetic and pre-diabetic hypertensive patients |
Date of disclosure of the study information | 2011/06/08 |
Last modified on | 2013/12/08 11:50:31 |
Aggressive antihypertensive treatment for protecting cardiovascular complications in diabetic and pre-diabetic hypertensive patients
APTEC trial
Aggressive antihypertensive treatment for protecting cardiovascular complications in diabetic and pre-diabetic hypertensive patients
APTEC trial
Japan |
1.Hypertensive patients with diabetes mellitus (DM), pre-diabetes: DM was defined as at least one of the following criteria: fasting blood glucose >=126mg/dl, 2-hour glucose in 75gOGTT >=200mg/dl, HbA1c >=6.1%, or treated diabetes.Pre-diabetes was diagnosed as HbA1c >=5.7%
Cardiology | Endocrinology and Metabolism |
Others
NO
To evaluate the successful control rate of BP, the change of the measure of target organ damage, and adverse effects.
Efficacy
Exploratory
Pragmatic
Not applicable
BP control rate: the percentage of attaining target home BP <125/75mmHg
BP: BP control rate and the degree of BP lowering at the end of the treatment
Renal function: the changing rate of serum creatinine (eGFR) and urinary microalbumin
Diabetes: changing rate of HbA1c and fasting blood glucose
Pulse wave velocity (PWV)
Augmentation index at radial artery
Baroreflex sensitivity (BRS)
Flow mediated dilatation (FMD)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Increase the dose of the drug.
30 | years-old | <= |
Not applicable |
Male and Female
1. Hypertension with dibetes mellitus or pre-diabetes.
2. Morning systolic blood pressure >=135 with self-monitoring BP at home
3. The age >=30 years
4. The patients were either never treated, single drug therapy (CCB or ACE-I, ARB), or double drug therapy in combination with CCB plus ACE-I, ARB.
1. Secondary hypertension
2. Patients with congestive heart failure, acute MI less than 6months, acute stroke less than 6months, atrial fibrilation, AV block, or significant arrhythmia.
3.Hepatic damage (AST, ALT >twice of upper limits, renal dysfunction (serum creatine
4. Allergy, or allergic reaction
5. Dementia from whom we cannot obtain informed consent.
6. pregnancy
7. for whom the attending doctor considerd he or she is not appropriate for the study.
60
1st name | |
Middle name | |
Last name | Kazuo Eguchi |
Jichi Medical University School of Medicine
Division of Cardiovascular Medicine, Department of Medicine
3311-1 Yakusiji,Shimotsuke, Tochigi 329-0498, Japan
0285-58-7344
1st name | |
Middle name | |
Last name | Kazuo Eguchi |
Jichi Medical University School of Medicine
Division of Cardiovascular Medicine, Department of Medicine
3311-1 Yakusiji,Shimotsuke, Tochigi 329-0498, Japan
0285-58-7344
ke112@jichi.ac.jp
Jichi Medical University,School of Medicine
Jichi Medical University,School of Medicine
Self funding
Japan
International University of Health and Welfare Hospital
NO
自治医科大学付属病院(栃木県)
国際医療福祉大学病院(栃木県)
2011 | Year | 06 | Month | 08 | Day |
Published
Completed
2009 | Year | 11 | Month | 17 | Day |
2009 | Year | 11 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 06 | Month | 01 | Day |
2011 | Year | 09 | Month | 01 | Day |
2011 | Year | 10 | Month | 01 | Day |
2011 | Year | 06 | Month | 08 | Day |
2013 | Year | 12 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005616